Your session is about to expire
← Back to Search
Cryotherapy for Esophageal Cancer
Study Summary
This trial will study the effects of a cryotherapy system on people with esophageal cancer who can't have surgery or have finished or declined systemic therapy.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are any participants younger than twenty-five years old taking part in this experiment?
"This clinical trial is open to all individuals aged 18-89. Other trials, targeted at minors and those over 65 respectively, offer opportunities for 10 and 378 patients."
Who is eligible to participate in this trial?
"This study aims to enroll 51 individuals with esophageal cancer aged 18-89. Applicants must meet the following criteria: possessing persistent esophageal cancer localized to a lumen, able to endure endoscopic procedures, and be male or female between 18-89 years of age. Additionally, prospective participants should have declined or completed systemic therapies prior to enrollment."
Are there any openings for individuals to participate in this trial?
"According to clinicaltrials.gov, this study is not presently open for recruitment as the last edit was made on July 22nd 2022. Nonetheless, 379 other medical trials are now looking for prospective candidates at present."
In which geographic regions is this trial being conducted?
"10 medical centres are partaking in this trial, including Dartmouth-Hotchcock Medical Center situated in Lebanon, Parkview Comprehensive Cancer Centre located in Fort Wayne and the Cancer Treatment Centers of America Western Regional Medical Centre based in Goodyear. There are 7 other sites involved as well."
Share this study with friends
Copy Link
Messenger